Likewise, the discovery of FGF23 has led to further insights into the pathogenesis of chronic kidney disease–mineral and bone disorder (CKD-MBD), accounting for the paradigm shift from the classic trade off hypothesis to an updated trade off hypothesis[5]. This evidence concerns the gene FGF23 and Marchiafava-Bignami disease.